Latest Breaking News On - Interstitial lung disease program - Page 1 : comparemela.com

Brainomix Achieves Breakthrough with FDA Clearance of e-Lung AI Software

·        Established market leader in stroke AI imaging receives its first FDA clearance in the lung imaging space.·        With this expanded foundation of AI-driven healthcare solutions, the Oxford-based company remains committed t.

United statesUniversity of chicagoSan diegoUnited kingdomDeji adegunsoyeAvalyn pharmaMichalis papadakisHeidelberg universityAmerican thoracic societyAssistant professorScientific directorInterstitial lung disease programChicago medicineAmerican journalCritical care medicineIdiopathic pulmonary fibrosis

Brainomix Achieves Breakthrough with FDA Clearance of e-Lung AI Software

Brainomix Achieves Breakthrough with FDA Clearance of e-Lung AI Software
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoUniversity of chicagoBaden wübergUnited kingdomSue charlesAvalyn pharmaJeff wyrtzenMichalis papadakisDeji adegunsoyePrnewswire brainomixUniversity of oxfordMarketing business developmentAmerican thoracic societyHeidelberg universityAssistant professor

Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024

Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Fernandoj martinezAgaplesion evangTejaswini kulkarniRare lung diseases at justus liebig universityAileron therapeutics incHost key opinion leader eventTreating idiopathic pulmonaryCritical care medicine divisionWeill cornellAssociate professorCritical care medicineInterstitial lung disease programSenior physicianIntensive care medicineChief physicianInternal intensive care medicine

Aileron Therapeutics to Host Key Opinion Leader Event on

Panel discussion will highlight LTI-03, Aileron’s novel Caveolin-1-related peptide, for the treatment of idiopathic pulmonary fibrosis.

Tejaswini kulkarniFernandoj martinezAgaplesion evangAileron therapeutics incRare lung diseases at justus liebig universityTreating idiopathic pulmonaryCritical care medicine divisionWeill cornellAssociate professorCritical care medicineInterstitial lung disease programSenior physicianIntensive care medicineChief physicianInternal intensive care medicineCentral hesse hospital

Pulmonary Fibrosis Foundation Names Dr Franck Rahaghi New President, CEO and Chief Medical Officer

Rahaghi Brings Over 25 Years of Clinical Care and Leadership to Growing FoundationCHICAGO , Sept. 5, 2023 /PRNewswire/ The Pulmonary Fibrosis F.

University of california at berkeleyUnited statesNew yorkUniversity of illinois at chicagoDavid mcninchJoseph laskyBill schmidtDorothy coyleFranck rahaghiDepartment of pulmonaryCare center networkCleveland clinic lerner college of medicineCare centerPulmonary hypertension associationAmerican college of chest physiciansPulmonary fibrosis foundation